Related Experiment Video
Updated: May 28, 2026

Monitoring Dynamic Changes In Mitochondrial Calcium Levels During Apoptosis Using A Genetically Encoded Calcium Sensor
Published on: April 1, 2011
Identification of a conserved anti-apoptotic protein that modulates the mitochondrial apoptosis pathway
Yu Zhang1, Elisabet Johansson, Marian L Miller
1School of Pharmacy, University of Cincinnati, Cincinnati, Ohio, United States of America.
Abstract:
Here we identified an evolutionarily highly conserved and ubiquitously expressed protein (C9orf82) that shows structural similarities to the death effector domain of apoptosis-related proteins. RNAi knockdown of C9orf82 induced apoptosis in A-549 and MCF7/casp3-10b lung and breast carcinoma cells, respectively, but not in cells lacking caspase-3, caspase-10 or both. Apoptosis was associated with activated caspases-3, -8, -9 and -10, and inactivation of caspases 10 or 3 was sufficient to block apoptosis in this pathway. Apoptosis upon knockdown of C9orf82 was associated with increased caspase-10 expression and activation, which was required for the generation of an 11 kDa tBid fragment and activation of Caspase-9. These data suggest that C9orf82 functions as an anti-apoptotic protein that modulates a caspase-10 dependent mitochondrial caspase-3/9 feedback amplification loop. We designate this ubiquitously expressed and evolutionarily conserved anti-apoptotic protein Conserved Anti-Apoptotic Protein (CAAP). We also demonstrated that treatment of MCF7/casp3-10b cells with staurosporine and etoposides induced apoptosis and knockdown of CAAP expression. This implies that the CAAP protein could be a target for chemotherapeutic agents.
Insights
Researchers discovered a conserved protein, C9orf82 (Conserved Anti-Apoptotic Protein - CAAP), that inhibits apoptosis. Its knockdown triggers cell death, suggesting CAAP as a potential target for cancer therapy.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Apoptosis is a crucial cellular process regulated by caspases.
- The role of conserved proteins in apoptosis regulation is not fully understood.
Purpose of the Study:
- To identify and characterize a novel protein involved in apoptosis regulation.
- To elucidate the mechanism by which C9orf82 influences apoptosis.
- To evaluate the potential of C9orf82 as a therapeutic target.
Main Methods:
- RNA interference (RNAi) for gene knockdown.
- Apoptosis assays in lung and breast carcinoma cell lines.
- Western blotting to detect protein expression and activation.
- Caspase activity assays.
Main Results:
- C9orf82, structurally similar to death effector domains, was identified as Conserved Anti-Apoptotic Protein (CAAP).
- RNAi-mediated knockdown of CAAP induced apoptosis in cancer cells, dependent on caspase-3 and caspase-10.
- CAAP knockdown led to caspase-10 activation, tBid generation, and caspase-9 activation, indicating a caspase-10 dependent mitochondrial feedback loop.
- CAAP knockdown sensitized cells to chemotherapy-induced apoptosis.
Conclusions:
- CAAP functions as an anti-apoptotic protein regulating a caspase-10 dependent mitochondrial amplification loop.
- CAAP is a potential therapeutic target for enhancing chemotherapy efficacy in cancer treatment.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
Caspases
Regulation of the Unfolded Protein Response

